Unit BIOTECHNOLOGICAL APPROACHES TO ONCOLOGICAL DISEASES
- Course
- Medical, veterinary and forensic biotechnological sciences
- Study-unit Code
- A001772
- Curriculum
- Medico
- Teacher
- Mario Mandala'
- Teachers
-
- Mario Mandala'
- Hours
- 42 ore - Mario Mandala'
- CFU
- 6
- Course Regulation
- Coorte 2025
- Offered
- 2026/27
- Learning activities
- Caratterizzante
- Area
- Discipline medico-chirurgiche e della riproduzione umana
- Sector
- MED/46
- Type of study-unit
- Opzionale (Optional)
- Type of learning activities
- Attività formativa monodisciplinare
- Language of instruction
- English
- Contents
- The biological background of anticancer agents: from chemo to personalised therapy and immunotherapy
Non melanoma skin cancers (NMSK): 1) Genomic features, Tumour microenvironment and clinical implications. 2) Discussion on clinical cases
Melanoma: Genomic features, Tumour microenvironment and clinical implications. 2) Discussion on clinical cases
Non small cell lung cancer (NSCLC) : Non Oncogene addicted tumors and treatment strategies. Discussion on clinical cases
NSCLC: Oncogene addicted tumors and treatment strategies.
Discussion on clinical cases
Study of DNA and RNA with high-throughput technologies (NGS, Nanostring, Microarray)
Hereditary cancers: genomic analyses and impact on counseling and patient management
Intratumoral Microbioma: From the bench to bedside
Pharmacological
features of new drugs - Reference texts
- Frontal lessons with interactive Q&A sessions
Review articles from main scientific journals - Educational objectives
- At the end of the course, students will be familiar with theoretical and
practical elements that guide the clinical application of biotecnological techniques, which are instrumental for diagnosis and therapy of the main
tumors.
Students will have the main elements that link the most modern biotechnological skills with the clinic, from the bench to the bedside
Finally, students will navigate in clinical cancer management by applying
the main knowledge for an integrated cancer approach
The internship in the lab will provide practical experience on most advanced high-throughput technologies (NGS, Nanostring, Microarray) - Prerequisites
- Cell Biology
Basic pharmacology
Knowledge of the main laboratory techniques - Teaching methods
- Frontal interactive lessons
Internship - Other information
- Lessons will be enriched through the active interactions of students with basic, translational and clinical researchers
- Learning verification modality
- Esame scritto con domande a risposte multiple
- Extended program
- The biological background of anticancer agents: from chemo to personalised therapy
Non melanoma skin cancers (NMSK): 1) Genomic features, Tumour microenvironment and clinical implications. 2) Discussion on clinical cases
Melanoma: Genomic features, Tumour microenvironment and clinical implications. 2) Discussion on clinical cases
Non small cell lung cancer (NSCLC) : Non Oncogene addicted tumors and treatment strategies. Discussion on clinical cases
NSCLC: Oncogene addicted tumors and treatment strategies.
Discussion on clinical cases
Study of DNA and RNA with high-throughput technologies (NGS, Nanostring, Microarray)
Hereditary cancers: genomic analyses and impact on counseling and patient management
Intratumoral Microbioma: From the bench to bedside
Pharmacological features of new drugs - Obiettivi Agenda 2030 per lo sviluppo sostenibile
- health and well-being